AAA Kaloyan Andonov – Page 12

Venturing continues to grow

GCV Analytics tracked 2,320 deals worth an estimated total of $109.23bn raised through 2017. The deal count was a minor increase on a year-to-year basis (6%) compared with the 2,173 transactions of 2016. The total value of corporate-backed VC rounds reached a new high, surpassing the $100bn mark. Nearly half of corporate-backed transactions in 2017… Continue reading Venturing continues to grow

Analysis: Boehringer Ingelheim starts 2018 with $300m fund

Pharmaceutical firm Boehringer Ingelheim has committed €150m in capital to its corporate venturing vehicle, Boehringer Ingelheim Venture Fund (BIVF), increasing its total investment in the fund to €250m ($300m). BIVF typically provides between €10m and €15m to each portfolio company in totL, where initial commitments vary between €500,000 and €3m. Its investment areas are focused… Continue reading Analysis: Boehringer Ingelheim starts 2018 with $300m fund

Teaser from the World of Corporate Venturing 2018 survey

GCV Analytics conducted its annual survey on the state of the corporate venturing industry in October and November 2017. A total of 60 respondents participated. The response rate was slightly lower than in previous years due to the considerable additional length and depth of the survey (we asked over 40 questions this time). However, we… Continue reading Teaser from the World of Corporate Venturing 2018 survey

Deal count bounces back

Corporate-backed deals tracked by GCV Analytics in November numbered 215, significantly higher than the 186 funding rounds in the same month last year. Investment value also increased by 84% to $8.05bn – up from $4.37bn in November 2016. The deal count in November was even more drastically higher compared with the 147 recorded in October… Continue reading Deal count bounces back